Ignite Creation Date:
2025-12-26 @ 11:13 AM
Ignite Modification Date:
2026-01-01 @ 2:28 AM
Study NCT ID:
NCT06895928
Status:
RECRUITING
Last Update Posted:
2025-04-22
First Post:
2025-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-28
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-20
First Submit QC Date:
None
Study First Post Date:
2025-03-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-21
Last Update Post Date:
2025-04-22
Last Update Post Date Type:
ACTUAL